Inflammatory bowel disease can be diagnosed through microbiome analysis in a non-invasive way

Reproducible biomarkers produced by several bacteria show potential as a non-invasive tool for IBD diagnosis, discriminating ulcerative colitis and Crohn’s disease patients from healthy individuals.

Gut bacteria improve autism-like behaviors in mice

Treatment with the probiotic Lactobacillus murinus improved social behavior and partially restored gut and brain function.

InnoGI Technologies: advancing gut microbiome research with mucus-enhanced models

Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…

Lallemand Health Solutions launches Cerenity, a clinically studied probiotic formula to support healthy aging

Cerenity™ improves mobility, strength, and muscle function in older adults by modulating the gut-muscle axis.

NIST redefines gut microbiome research with breakthrough reference material

The Human Gut Microbiome Reference Material (RM) promises to standardize and enhance research efforts in a field poised to transform healthcare.

Gut microbes linked to inflammatory bowel diseases worsen colitis in mice

Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…

Sugary drinks may raise diabetes risk by altering gut bacteria

The findings of a recent study suggest a potential role of gut microbiota and microbial metabolites in the link between sugar-sweetened beverages intake and diabetes risk.

MaaT013 cleared for pediatric trials: EMA approval marks key milestone for microbiome therapy in aGvHD

MaaT013, a Microbiome Ecosystem Therapy™ (MET), is designed to restore the gut microbiome in pediatric patients aged 6 to 18 years with steroid-resistant aGvHD.

Skin microbiome

The skin is not merely a protective barrier; it is a complex, dynamic ecosystem populated by billions of microorganisms that play essential roles in maintaining skin health.

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment. 

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top